Data from The Cancer Genome Atlas (TCGA) integrated into the Pathology Atlas (The Pathology Atlas, version: 20.1) (Uhlén et al., 2005; Uhlén et al., 2015; Uhlen et al., 2017) have shown increased expression of NIBAN1 in several types of cancer, many has been described in both early carcinogenesis process (Adachi et al., 2004; Matsumoto et al., 2006; Ito et al., 2010) and associated with stress response (Adachi et al., 2004; Sun et al., 2007; Ji et al., 2012; Luo et al., 2017; Qaisiya et al., 2017; Nozima et al., 2019; Pällmann et al., 2019; Yim et al., 2020). Here, NIBAN1 is linked to cancer.